@article{0813b021e0f6480b879afc255cacebc3,
title = "In Vivo Brain Sodium Disequilibrium in ATP1A3-Related Rapid-Onset Dystonia-Parkinsonism",
author = "Jannik Prasuhn and Martin G{\"o}ttlich and Grosser, \{Sinja S\} and Katharina Reuther and Britt Ebeling and Alexander M{\"u}nchau and Nagel, \{Armin M\} and Norbert Br{\"u}ggemann",
note = "Funding Information: J.P. received funding from the Parkinson's Foundation, the Deutsche Parkinsongesellschaft, and the Deutsche Forschungsgemeinschaft via the Clinician Scientist School L{\"u}beck (DFG- GEPRIS 413535489). N.B. received funding from the Deutsche Forschungs-Gemeinschaft (BR4328.2–1 [FOR2488], GRK1957). Open Access funding enabled and organized by Projekt DEAL. Open access funding enabled and organized by Projekt DEAL. Funding Information: A.M.—Stock Ownership in medically related fields – none; Intellectual Property Rights – none; Consultancies – Desitin, Merz Pharmaceuticals, Admedicum, PTC Therapeutics; Expert Testimony – none; Advisory Boards – German Tourette Syndrome Association and Alliance of patients with chronic rare diseases; Employment – University Medical Center Schleswig Holstein; Partnerships – none; Contracts – none; Honoraria – Allergan, Ipsen, Merz Pharmaceuticals, Actelion, GlaxoSmithKline, Desitin, Teva, and Takeda; Royalties − none; Grants – Possehl‐Stiftung (L{\"u}beck, Germany), Margot und J{\"u}rgen Wessel Stiftung (L{\"u}beck, Germany), Tourette Syndrome Association (Germany), Interessenverband Tourette Syndrom (Germany), CHDI, Damp‐Stiftung (Kiel, Germany); Deutsche Forschungsgemeinschaft (DFG): projects 1692/3–1, 4–1, SFB 936, and FOR 2698 (project numbers 396,914,663, 396,577,296, 396,474,989); European Reference Network – Rare Neurological Diseases (ERN – RND; Project ID No 739510); Other – none.",
year = "2022",
month = apr,
doi = "10.1002/mds.28954",
language = "English",
volume = "37",
pages = "877--879",
journal = "Movement disorders : official journal of the Movement Disorder Society",
issn = "0885-3185",
publisher = "John Wiley \& Sons Inc.",
number = "4",
}
SDG 3 – Gesundheit und Wohlergehen
SDG 10 – Weniger Ungleichheiten